BAKER BROS. ADVISORS LP purchased 0.6% of their position (28.87K shares) of ENTRADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $261.8K — a small addition. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 11/24/2025ACC: 0001193125-25-293698
10% Owner
Since Dec 2021
+28.87K
Net shares
Net buyer
$261.8K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
28.87K acquired
Non-Derivative Transactions4
Common Stock
Indirect
Shares
+1.21K
Price / share
$9.07
Trade value
$11K
% of position
0.3%
11/20/2025
378.94K→380.15K
Common Stock
Indirect
Shares
+13.39K
Price / share
$9.07
Trade value
$121.39K
% of position
0.3%
11/20/2025
4.66M→4.68M
Common Stock
Indirect
Shares
+1.19K
Price / share
$9.07
Trade value
$10.76K
% of position
0.3%
11/20/2025
380.15K→381.34K
Common Stock
Indirect
Shares
+13.08K
Price / share
$9.07
Trade value
$118.69K
% of position
0.3%
11/20/2025
4.68M→4.69M
Total
Net shares
+28.87K
Net value
$261.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/20/2025 | P · Purchase | +1.21K | $9.07 | $11K | 0.3% | 378.94K | 380.15K |
| Common Stock Indirect | 11/20/2025 | P · Purchase | +13.39K | $9.07 | $121.39K | 0.3% | 4.66M | 4.68M |
| Common Stock Indirect | 11/20/2025 | P · Purchase | +1.19K | $9.07 | $10.76K | 0.3% | 380.15K | 381.34K |
| Common Stock Indirect | 11/20/2025 | P · Purchase | +13.08K | $9.07 | $118.69K | 0.3% | 4.68M | 4.69M |
| Total | +28.87K | $261.85K | ||||||
Derivative Transactions0
No derivative transactions reported